Market Research Logo

Global Irritable Bowel Syndrome Treatment Market by Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, and others), Medical Condition (IBS-constipation and IBS-diarrhea), Distribution Channel (Hospital Pharmacies, Online Pharmacies,

Global Irritable Bowel Syndrome Treatment Market by Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, and others), Medical Condition (IBS-constipation and IBS-diarrhea), Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) and Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

The treatment of irritable bowel syndrome majorly revolves around relieving the patient from the symptoms associated with the condition, as the causes behind occurrence of irritable bowel syndrome are yet to be established. Patients suffering from irritable bowel syndrome show symptoms such as abdominal pain, diarrhea, and constipation. Long-term and recurring presence of these symptoms signals the possibility of irritable bowel syndrome. The treatment depends on severity of these symptoms, which are distinguished as mild, moderate, and severe. Mild symptoms do not significantly affect the quality of life. However, severe symptoms are more frequent and intense and need to be addressed. The disease is often linked with dietary, lifestyle factors, and stress, which can be controlled by managing stress levels, diet, and exercise. Severe symptoms need to be treated through medication prescribed by physicians. Two major therapy options are available for the treatment of IBS, namely, medical or drug therapy and nutritional therapy. Medical therapy includes drugs for relieving the symptoms and nutritional therapy by using fibers and probiotics or prebiotics depending on the situation.
Market Dynamics
The rise in number of gastrointestinal disorders are leading to increasing prevalence of irritable bowel syndrome, for which various companies such as Ironwood Pharmaceuticals, Inc. as well as NGOs conduct mass workshops for educating the people to incorporate healthy food habits as a major precaution towards prevention of IBS. Furthermore, major growth drivers for the irritable bowel syndrome treatment market are expected launches of various pipeline drugs for the treatment during the forecast period and increase in levels of stress associated with changing lifestyle as people suffering from IBS have a colon with sensitivity towards certain foods and stress. According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. The large population of stress and anxiety disorder patients are expected to fuel the growth of the global irritable bowel syndrome treatment market.
Market Taxonomy
This report segments the global irritable bowel syndrome treatment market on the basis of drug type, medical condition, and distribution channel. On the basis of drug type, the global irritable bowel syndrome treatment market is segmented into lubiprostone, linaclotide, eluxadoline, rifaximin, Ramosetron Hydrochloride and others. Medical conditions of irritable bowel syndrome includes IBS-constipation and IBS-diarrhea. Irritable bowel syndrome treatment market is segmented by distribution channel as hospital pharmacies, online pharmacies and retail pharmacies.
Key features of the study:

  • This report provides in-depth analysis of irritable bowel syndrome treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global irritable bowel syndrome treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories*, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc., Novartis AG, GlaxoSmithKline plc., Ironwood Pharmaceuticals, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global irritable bowel syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the Irritable Bowel Syndrome Treatment Market
Detailed Segmentation:
  • Global Irritable Bowel Syndrome Treatment Market, By Drug Type:
  • Lubiprostone
  • Linaclotide
  • Eluxadoline
  • Rifaximin
  • Ramosetron Hydrochloride
  • Others
  • Global Irritable Bowel Syndrome Treatment Market, By Medical Condition:
  • IBS-Constipation
  • IBS-Diarrhea
  • Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Global Irritable Bowel Syndrome Treatment Market, By Geography:
  • North America
  • By Drug Type:
  • Lubiprostone
  • Linaclotide
  • Eluxadoline
  • Rifaximin
  • Ramosetron Hydrochloride
  • Others
  • By Medical Condition:
  • IBS-Constipation
  • IBS-Diarrhea
  • By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Drug Type:
  • Lubiprostone
  • Linaclotide
  • Eluxadoline
  • Rifaximin
  • Ramosetron Hydrochloride
  • Others
  • By Medical Condition:
  • IBS-Constipation
  • IBS-Diarrhea
  • By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • U.K.
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • By Drug Type:
  • Lubiprostone
  • Linaclotide
  • Eluxadoline
  • Rifaximin
  • Ramosetron Hydrochloride
  • Others
  • By Medical Condition:
  • IBS-Constipation
  • IBS-Diarrhea
  • By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • China
  • Japan
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
  • By Drug Type:
  • Lubiprostone
  • Linaclotide
  • Eluxadoline
  • Rifaximin
  • Ramosetron Hydrochloride
  • Others
  • By Medical Condition:
  • IBS-Constipation
  • IBS-Diarrhea
  • By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • Mexico
  • Rest of Latin America
  • Middle East
  • By Drug Type:
  • Lubiprostone
  • Linaclotide
  • Eluxadoline
  • Rifaximin
  • Ramosetron Hydrochloride
  • Others
  • By Medical Condition:
  • IBS-Constipation
  • IBS-Diarrhea
  • By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • Israel
  • Rest of Middle East
  • Africa
  • By Drug Type:
  • Lubiprostone
  • Linaclotide
  • Eluxadoline
  • Rifaximin
  • Ramosetron Hydrochloride
  • Others
  • By Medical Condition:
  • IBS-Constipation
  • IBS-Diarrhea
  • By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • South Africa
  • Rest of Africa
  • Company Profiles
  • Abbott Laboratories *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Future Plans
  • Synergy Pharmaceuticals, Inc.
  • Sucampo Pharmaceuticals, Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Novartis AG
  • GlaxoSmithKline plc.
  • Ironwood Pharmaceuticals, Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet By Drug Type
Market Snippet By Medical Condition
Market Snippet By Distribution Channel
Market Snippet By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Consumer Trends
Impact Analysis
FDA Approval Timeline
PEST Analysis
Probiotics & Prebiotics
4. Global Irritable Bowel Syndrome Treatment Market, By Drug Type, 2017 - 2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017 - 2025
Segment Trends
Lubiprostone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Linaclotide
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Eluxadoline
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Rifaximin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Ramosetron Hydrochloride
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
5. Global Irritable Bowel Syndrome Treatment Market, By Medical Condition, 2017 - 2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017 - 2025
Segment Trends
IBS - Constipation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
IBS - Diarrhea
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
6. Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, 2017 - 2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017 - 2025
Segment Trends
Hospitals Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
7. Global Irritable Bowel Syndrome Treatment Market, By Regions, 2017 - 2025 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2016 and 2025 (%)
Y-o-Y Growth Analysis, For Regions, 2017 - 2025
North America
Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
U.K.
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
China
Japan
ASEAN
Rest of APAC
Latin America
Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
Mexico
Rest of Latin America
Africa
Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
South Africa
Rest of Africa
Middle East
Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
Market Size and Forecast, By Country , 2017 - 2025 (US$ Mn)
Israel
Rest of Middle East
8. Competitive Landscape
Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
Abbott Laboratories
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Synergy Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Sucampo Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Valeant Pharmaceuticals International, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Ardelyx, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Astellas Pharma Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Novartis AG
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
GlaxoSmithKline plc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Ironwood Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 43 market data tables and 34 figures on "Irritable Bowel Syndrome Treatment Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report